Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Clinical Rheumatology

• Publication date

  2017-01-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10067-016-3498-0PMID 28050648
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Study of clinical utility of antibodies to phosphatidylserine/prothrombin complex in Asian-Indian patients with suspected APS

  2018cited by this paper
• Antibodies to Phosphatidylserine/Prothrombin Complex in Antiphospholipid Syndrome: Analytical and Clinical Perspectives.

  2016cited by this paper
• Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes

  2015influential reference
• Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome

  2015cited by this paper
• The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation

  2014cited by this paper
• Lupus anticoagulant diagnosis in activated partial thromboplastin time mixing test: optimization of the index of circulating anticoagulant cut-off value.

  2014cited by this paper
• 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends.

  2014cited by this paper
• A novel ELISA system for simultaneous detection of six subclasses of anti-phospholipid antibodies for prediction of thrombotic complications among SLE patients.

  2014cited by this paper
• Silvia Pierangeli, PhD (1955–2013)

  2014cited by this paper
• Antiphospholipid antibody testing and standardization

  2014cited by this paper
• Standardization of Antiphospholipid Antibody Testing—Historical Perspectives and Ongoing Initiatives

  2014cited by this paper
• Antiphosphatidylserine/Prothrombin Antibodies (aPS/PT) as Potential Markers of Antiphospholipid Syndrome

  2013influential reference
• Antibodies to phosphatidylserine/prothrombin complex as an additional diagnostic marker of APS?

  2012cited by this paper
• Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome

  2012influential reference
• Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities

  2012cited by this paper
• Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant

  2012cited by this paper
• Modified phosphatidylserine-dependent antiprothrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies

  2011cited by this paper
• Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called ‘seronegative APS’)

  2011cited by this paper
• Modified phosphatidylserine-dependent antithrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies

  2011cited by this paper
• Antiprothrombin antibody: why do we need more assays?

  2010cited by this paper
• Update of the guidelines for lupus anticoagulant detection

  2009cited by this paper
• International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome(APS)

  2008cited by this paper
• Antiprothrombin antibody testing: detection and clinical utility.

  2008cited by this paper
• The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.

  2006cited by this paper
• International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

  2006cited by this paper
• Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.

  2003cited by this paper
• Specificities, properties, and clinical significance of antiprothrombin antibodies.

  2003cited by this paper
• Seronegative antiphospholipid syndrome

  2003cited by this paper
• Hypercoagulability syndromes.

  2001cited by this paper
• Update on antiphospholipid antibodies

  2000cited by this paper
• Occurrence of anti-prothrombin and anti-beta2-glycoprotein I antibodies in patients with history of thrombosis.

  1999cited by this paper
• Anti-prothrombin antibodies and the lupus anticoagulant.

  1988cited by this paper

• The diagnostic and prognostic values of non-criteria antiphospholipid antibodies in obstetric antiphospholipid syndrome

  2026cites this paper
• Added value of antiphosphatidylserine/prothrombin antibodies in the workup of obstetric antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.

  2023cites this paper
• Beyond the classics: The emerging value of anti-phosphatidylserine/prothrombin antibodies in antiphospholipid syndrome.

  2023cites this paper
• First-trimester serum antiphosphatidylserine antibodies serve as candidate biomarkers for predicting pregnancy-induced hypertension

  2023cites this paper
• Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

  2022cites this paper
• Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added

  2022cites this paper
• Antiphosphatidylserine/prothrombin antibodies (aPS/PT) and risk of obstetric anti‐phospholipid syndrome

  2022cites this paper
• Prevalence of aPhosphatidylserine/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: A systematic review and meta-analysis.

  2022cites this paper
• Evaluation of the Diagnostic Value of Non-criteria Antibodies for Antiphospholipid Syndrome Patients in a Chinese Cohort

  2021cites this paper
• Antiphospholipid Syndrome.

  2020cites this paper
• Non-Criteria Antiphospholipid Antibodies: Risk Factors for Endothelial Dysfunction in Women with Pre-Eclampsia

  2020cites this paper
• Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome

  2020cites this paper
• Antiphospholipid antibody syndrome with thrombotic splenic infarcts associated with acute cytomegalovirus infection

  2019cites this paper
• Characteristics of pregnancy complications and treatment in obstetric antiphospholipid syndrome in China

  2019cites this paper
• Should aPS/PT Be Incorporated into the Routine Serological Tests in the Diagnosis of Antiphospholipid Syndrome?

  2019cites this paper
• Study of clinical utility of antibodies to phosphatidylserine/prothrombin complex in Asian-Indian patients with suspected APS

  2018influential citation
• Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome

  2017cites this paper
• Antibodies to Phosphatidylserine/Prothrombin Complex in Antiphospholipid Syndrome: Analytical and Clinical Perspectives.

  2016cites this paper